comparemela.com

Latest Breaking News On - Cancer therapy advisor - Page 12 : comparemela.com

Cervical Cancer Screening Guidelines: Time for a Change?

It may be time to revise US screening guidelines for cervical cancer in patients age 65 and older, according to researchers.

Study on Lenvatinib Overspending Prompts Manufacturer Promise of Dose Exchange Revamp

The dose-specific packaging of lenvatinib may cost endometrial cancer patients and payers as much as $168 million annually for dose reductions.

vimarsana © 2020. All Rights Reserved.